Keywords: دوزوروبیسین لیپوزومال; Kaposi sarcoma herpesvirus; Human herpesvirus-8; Multicentric Castleman disease; Human interleukin-6; Viral interleukin 6; Rituximab; Liposomal doxorubicin;
مقالات ISI دوزوروبیسین لیپوزومال (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: دوزوروبیسین لیپوزومال; Lymphoma; Chemotherapy; Anthracyclines; Liposomal doxorubicin; Acute decompensated heart failure; Cardio-oncology;
Keywords: دوزوروبیسین لیپوزومال; Cancer-associated fibroblasts; Tumor microenvironment; Navitoclax; Liposomal doxorubicin; Combination therapy; Tumor penetration;
Keywords: دوزوروبیسین لیپوزومال; NPC; nasopharyngeal carcinoma; NPC-TW01,06 and 07; nasopharyngeal carcinoma, Taiwan, cell line-01, 06 and 07; C-P; control-peptide; L-P; L-peptide; Dox; doxorubicin; L-D; liposomal doxorubicin; L-P-L-D; L-peptide-linked liposomal doxorubicin; C-P-L-P; con
Keywords: دوزوروبیسین لیپوزومال; Liposomal doxorubicin; Plasma filtration; Toxicity; Drug delivery system
Clinical response to liposomal doxorubicin and rituximab in HHV-8-associated multicentric Castleman's disease in an HIV-positive patient
Keywords: دوزوروبیسین لیپوزومال; Multicentric Castleman's disease; HIV; HHV-8; Liposomal doxorubicin; Rituximab;
A comparison of overall survival with 40 and 50Â mg/m2 pegylated liposomal doxorubicin treatment in patients with recurrent epithelial ovarian cancer: Propensity score-matched analysis of real-world data
Keywords: دوزوروبیسین لیپوزومال; Ovarian neoplasms; Liposomal doxorubicin; Propensity score; Mortality; Hand-foot syndrome; Stomatitis;
IGF1-R inhibition and liposomal doxorubicin: Progress in preclinical evaluation for the treatment of adrenocortical carcinoma
Keywords: دوزوروبیسین لیپوزومال; Adrenocortical carcinoma; Liposomal doxorubicin; Immunoliposomes; Caelyx®; NCI-H295R; SJ-ACC3; MUC-1; Ab; antibody; ACC; adrenocortical carcinoma; Chol; cholesterol; DSPE-mPEG; 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glyco
Nonpegylated Liposomal Doxorubicin as a Component of R-CHOP Is an Effective and Safe Alternative to Conventional Doxorubicin in the Treatment of Patients With Diffuse Large B-Cell Lymphoma and Preexisting Cardiac Diseases
Keywords: دوزوروبیسین لیپوزومال; Cardiac toxicity; DLBCL; Elderly; Liposomal doxorubicin; Reduced LVEF
The PEGylated liposomal doxorubicin improves the delivery and therapeutic efficiency of 188Re-Liposome by modulating phagocytosis in C26 murine colon carcinoma tumor model
Keywords: دوزوروبیسین لیپوزومال; Colon cancer; Pretreatment; Bio-distribution; Liposomal doxorubicin; Internal radiotherapy; 188Re-Liposome;
Enhanced antitumor and anti-metastasis efficiency via combined treatment with CXCR4 antagonist and liposomal doxorubicin
Keywords: دوزوروبیسین لیپوزومال; Metastasis; CXCR4 antagonist; Combined treatment; Liposomal doxorubicin;
Combined mTOR inhibitor rapamycin and doxorubicin-loaded cyclic octapeptide modified liposomes for targeting integrin α3 in triple-negative breast cancer
Keywords: دوزوروبیسین لیپوزومال; Triple-negative breast cancer; Liposomal doxorubicin; Targeting delivery; Rapamycin; Combined therapy
Ultrasound Improves the Uptake and Distribution of Liposomal Doxorubicin in Prostate Cancer Xenografts
Keywords: دوزوروبیسین لیپوزومال; Ultrasound exposure; Liposomal doxorubicin; Drug delivery; Drug release; Microdistribution; Biodistribution;
Bi-weekly liposomal doxorubicin for advanced breast cancer in elderly women (≥ 70 years)
Keywords: دوزوروبیسین لیپوزومال; Anthracyclines; Breast cancer; Chemotherapy; Elderly; Liposomal doxorubicin; Toxicity
Combination radiofrequency (RF) ablation and IV liposomal heat shock protein suppression: Reduced tumor growth and increased animal endpoint survival in a small animal tumor model
Keywords: دوزوروبیسین لیپوزومال; Radiofrequency; Tumor ablation; Heat shock protein; Liposomal quercetin; Liposomal doxorubicin
Use of macrophages to deliver therapeutic and imaging contrast agents to tumors
Keywords: دوزوروبیسین لیپوزومال; Macrophage; Liposomal doxorubicin; Drug delivery; Tumor target
Case histories: breast cancer
Keywords: دوزوروبیسین لیپوزومال; Anthracycline; Breast cancer; Elderly patients; HER2-positive; Liposomal doxorubicin; Trastuzumab; Triple-negative;
Simultaneous analysis of liposomal doxorubicin and doxorubicin using capillary electrophoresis and laser induced fluorescence
Keywords: دوزوروبیسین لیپوزومال; Doxorubicin; Liposomal doxorubicin; Capillary electrophoresis; Laser induced fluorescence; Stability
Therapeutic efficacy and microSPECT/CT imaging of 188Re-DXR-liposome in a C26 murine colon carcinoma solid tumor model
Keywords: دوزوروبیسین لیپوزومال; Colon cancer; Combination therapy; Liposomal doxorubicin; Liposome; Micro-SPECT/CT; Radiochemotherapeutics; Rhenium-188
Phase II trial of carboplatin and distearoylphosphatidylcholine pegylated liposomal doxorubicin (Lipo-Dox®) in recurrent platinum-sensitive ovarian cancer following front-line therapy with paclitaxel and platinum
Keywords: دوزوروبیسین لیپوزومال; Liposomal doxorubicin; Recurrent ovarian cancer; Platinum-sensitive
Predisposing risk factors for palmar-plantar erythrodysesthesia when using liposomal doxorubicin to treat recurrent ovarian cancer
Keywords: دوزوروبیسین لیپوزومال; Liposomal doxorubicin; Plantar-palmar erythrodysesthesia; Ovarian cancer
Improving the therapeutic index of anthracycline chemotherapy: Focus on liposomal doxorubicin (Myocet™)
Keywords: دوزوروبیسین لیپوزومال; Liposomal doxorubicin; Anthracycline; Cardiotoxicity; Metastatic breast cancer
Gemcitabine and pegylated liposomal doxorubicin alternating with cisplatin plus cyclophosphamide in platinum refractory/resistant, paclitaxel-pretreated, ovarian carcinoma
Keywords: دوزوروبیسین لیپوزومال; Gemcitabine; Liposomal doxorubicin; Cisplatin; Cyclophosphamide; Chemotherapy; Resistant; Refractory; Ovarian cancer
Phase I/II study of gemcitabine with pegylated liposomal doxorubicin as first-line therapy in Asian women with metastatic breast cancer
Keywords: دوزوروبیسین لیپوزومال; Metastatic breast cancer; Gemcitabine; Liposomal doxorubicin
Paclitaxel, carboplatin and pegylated liposomal doxorubicin in ovarian and peritoneal carcinoma: A phase I study of the Gynecologic Oncology Group
Keywords: دوزوروبیسین لیپوزومال; Paclitaxel; Carboplatin; Liposomal doxorubicin; First line therapy in ovarian; Peritoneal and tubal carcinoma;
Evaluation of pegylated liposomal doxorubicin (Doxil) as second-line chemotherapy of squamous cell carcinoma of the cervix: A phase II study of the Gynecologic Oncology Group
Keywords: دوزوروبیسین لیپوزومال; Cervical cancer; Chemotherapy; Liposomal doxorubicin; Anthracycline
Phase II study of pegylated liposomal doxorubicin HCl (Caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small cell lung cancer
Keywords: دوزوروبیسین لیپوزومال; Small cell lung cancer; Second-line chemotherapy; Liposomal doxorubicin; Caelyx; Relapsed lung cancer; Refractory lung cancer
A randomised phase II study of two different schedules of pegylated liposomal doxorubicin in metastatic breast cancer (EORTC-10993)
Keywords: دوزوروبیسین لیپوزومال; Metastatic breast cancer; Liposomal doxorubicin
Delivery of Liposomal Doxorubicin (Doxil) in a Breast Cancer Tumor Model: Investigation of Potential Enhancement by Pulsed-High Intensity Focused Ultrasound Exposure
Keywords: دوزوروبیسین لیپوزومال; pulsed-high intensity focused ultrasound; liposomal doxorubicin; enhanced delivery; acoustic radiation forces;
Skin toxicity associated with pegylated liposomal doxorubicin (40 mg/m2) in the treatment of gynecologic cancers
Keywords: دوزوروبیسین لیپوزومال; Liposomal doxorubicin; Skin toxicity; Palmar-plantar erythrodysesthesia; Gynecologic cancer;
Phase II trial of liposomal doxorubicin at 40 mg/m2 every 4 weeks in endometrial carcinoma: A Gynecologic Oncology Group Study
Keywords: دوزوروبیسین لیپوزومال; First-line therapy; Disseminated endometrial carcinoma; Liposomal doxorubicin;
Gemcitabine and liposomal doxorubicin in the salvage treatment of ovarian cancer: Updated results and long-term survival
Keywords: دوزوروبیسین لیپوزومال; Gemcitabine; Liposomal doxorubicin; Recurrent ovarian cancer;
Liposomes targeted via two different antibodies: Assay, B-cell binding and cytotoxicity
Keywords: دوزوروبیسین لیپوزومال; DXR; doxorubicin; mAb; monoclonal antibody; SL; non-targeted long-circulating (Stealth®) liposomes; SIL; long-circulating antibody-targeted liposomes (Stealth® immunoliposomes); αCD19; anti-CD19 mAb; αCD20; anti-CD20 mAb (Rituxan); HSPC; hydrogenated